Web Results

opinion - Third Circuit


Aug 16, 2016 ... Appellants v. WIDENER UNIVERSITY SCHOOL OF LAW. ______. On Appeal from the ..... Welfare Fund v. AstraZeneca ..... Marcus v. BMW of N. Am., .... C. P. Goldberg et al., The Place of Reliance in Fraud, 48. ARIZ. L. REV.

amicus brief - Federal Trade Commission


Jun 16, 2015 ... (consolidated). American Sales Co., et al.,. Plaintiffs-Appellants, v. Warner- Chilcott ... Joel Marcus. Director of ..... Ins. Co. v. AstraZeneca, No.



Jan 21, 2015 ... AstraZeneca AB, et al., Defendants–Appellants, v. ... AstraZeneca sells a heartburn drug called Nexium and owns several ..... (citing Marcus v.

Intellectual Property Proceedings in Federal Court for 2004 | IPPractice


ET AL v. THE NIAGARA PARKS COMMISSION, Trade Mark Infringement, 2004- 01-20, Spiegel Sohmer .... T-260-04, ASTRAZENECA CANADA INC. v. ..... The Body Shop International PLC, Trade Mark Expungement, 2004-03-29, Macera ..... Trade Mark Infringement, 2004-07-06, Ridout & Maybee; GALLIE, MARCUS;.

Same Company, Same Fraud: Texas Intervenes in AstraZeneca Suit ...


Oct 9, 2014 ... Zayas and Miksell-Branch v. AstraZeneca, et al.). The suit alleges that AstraZeneca illegally promoted off-label uses for the company's ...

Class Action Lawyers, Attorneys, Complex Litigation | Schneider ...


Joint School District No.2 et al View Case »; Aalen et al v. The Hertz Corporation ... View Case »; Abner v. State of Illinois Department of Transp View Case »; Abney et al v. ..... Astrazeneca L P View Case »; Anderson v. AstraZeneca LP View ...

In re Ambulatory Pain Pump-Chondrolysis Products Liability Litigation


Apr 14, 2010 ... Inc.; Zimmer Holdings, Inc.; AstraZeneca PLC; AstraZeneca Pharmaceuticals LP; AstraZeneca LP; .... Andrew Gilmore, et al. v. DJO, Inc., et al. ... al. v. AstraZeneca Pharmaceuticals, LP, et al., C.A. No. .... Marcus J. Suhn v. Breg ...

Critical ages in the life-course of the adult brain: nonlinear ... - NCBI


May 2, 2013 ... Parts of these data have been previously published (e.g. Fjell et al., 2009c), and ... Marcus et al., 2007), n = 309, 18–94 years (44.5); Sample 4 (Raz et al., .... showed the largest effects, followed by the lateral ventricles (z = 2.15 vs. .... Global Clinical Development, Elan Corporation plc, Forest Laboratories, ...

Ziprasidone Augmentation of Escitalopram for Major Depressive ...


Jun 18, 2015 ... Results. Rates of clinical response (35.2% vs. 20.5%, p=0.04) and mean ..... [ PubMed]. 12. Papakostas GI, Petersen TJ, Nierenberg AA, et al.

The full blood count as a biomarker of outcome and toxicity in ...


Sep 29, 2016 ... M5G2M9, Toronto, Canada; Astrazeneca plc, Melbourn Science ... Marcus O. Butler, ..... C., J. Schachter, G. V. Long, A. Arance, J. J. Grob, L. Mortier, et al. ... V. Makarov, T. Merghoub, J. Yuan, J. M. Zaretsky, A. Desrichard, et al ...

More Info

Mylan Pharmaceuticals, Inc. v. Warner Chilcott plc, et al. (166.21 KB)


Sep 30, 2015 ... JOEL MARCUS. Director of .... Gen. Indus. Corp. v. Hartz Mtn. Corp.,. 810 F.2d 795 (8th Cir. 1987) . .... New York v. Actavis PLC, ... Astrazeneca Pharms., L.P., .... G. Michael Allen et al., Physician Awareness of Drug Cost:.

Perceived Risk of Severe Respiratory Syncytial Virus Disease and ...


Sep 22, 2015 ... <sup>7</sup>AstraZeneca, Gaithersburg, MD, USA. <sup>8</sup>ICON, Vancouver, BC, Canada. Veena R. Kumar, AstraZeneca, One MedImmune Way, Gaithersburg, ...

AstraZeneca Mölndal Presentation PDF 13683KB


Marcus Schindler (VP, Head of Cardiovascular & Metabolic Disease iMed). 15.15 -15.45 ..... Data from IV EPO taken from Figure 1 in MacDougall, et al. J Am Soc ...